In contrast, another study showed that LOXL4 downregulation promotes primary tumor growth and lung metastasis in mouse models of breast cancer, and that low LOXL4 expression is associated with poor overall survival of breast cancer patients [105]. Here, LOXL4 is linked to breast cancer.